Interstitial Lung Disease Caused by Apalutamide for Metastatic Castration-Sensitive Prostate Cancer

被引：0
|
作者：
del Castillo-Acuna, Rocio [1 ]
Serradilla, Ana [2 ,3 ]
Lopez-Campos, Fernando [4 ]
Counago, Felipe [5 ,6 ]
机构：
[1] Hosp Univ Punta Europa, Dept Radiat Oncol, Algeciras, Spain
[2] Complejo Hosp Jaen, Dept Radiat Oncol, Jaen, Spain
[3] Hosp Univ Ramon & Cajal, Dept Radiat Oncol, Madrid, Spain
[4] Hosp San Francisco Asis, Dept Radiat Oncol GenesisCare, Madrid, Spain
[5] Hosp Vithas La Milagrosa, Dept Radiat Oncol GenesisCare, Madrid, Spain
[6] GenesisCare Espana, Nacl Clin & Invest, Madrid, Spain
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2024年 / 60卷 / 08期
关键词：
D O I：
10.1016/j.arbres.2024.04.009
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [1] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Chi, Kim N.
    Agarwal, Neeraj
    Bjartell, Anders
    Chung, Byung Ha
    Pereira de Santana Gomes, Andrea J.
    Given, Robert
    Juarez Soto, Alvaro
    Merseburger, Axel S.
    Ozguroglu, Mustafa
    Uemura, Hirotsugu
    Ye, Dingwei
    Deprince, Kris
    Naini, Vahid
    Li, Jinhui
    Cheng, Shinta
    Yu, Margaret K.
    Zhang, Ke
    Larsen, Julie S.
    McCarthy, Sharon
    Chowdhury, Simon
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 13 - 24
  • [2] Use of Apalutamide for metastatic, castration-sensitive Prostate Cancer
    Thomas, C.
    UROLOGE, 2019, 58 (12): : 1496 - 1497
  • [3] Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer
    Sheridan M. Hoy
    Drugs, 2020, 80 : 1579 - 1585
  • [4] Apalutamide for the treatment of metastatic castration-sensitive prostate cancer
    Dror, Corinne Maurice
    Chi, Kim Nguyen
    FUTURE ONCOLOGY, 2020, 16 (35) : 2905 - 2916
  • [5] Re: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 202 (04): : 661 - 661
  • [6] Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer
    Hoy, Sheridan M.
    DRUGS, 2020, 80 (15) : 1579 - 1585
  • [7] A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer
    Kwon, Daniel Hyuck-Min
    Friedlander, Terence
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [8] A cost-utility analysis of apalutamide for metastatic castration-sensitive prostate cancer
    Parmar, Ambica
    Timilshina, Narhari
    Emmenegger, Urban
    Smoragiewicz, Martin
    Sander, Beate
    Alibhai, Shabbir
    Chan, Kelvin K. W.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (03): : E126 - E131
  • [9] The addition of apalutamide to ADT in the treatment of metastatic castration-sensitive prostate cancer: safety and efficacy
    Barata, Pedro
    Swami, Umang
    Agarwal, Neeraj
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (03) : 147 - 150
  • [10] Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer
    Fukuokaya, Wataru
    Mori, Keiichiro
    Yanagisawa, Takafumi
    Urabe, Fumihiko
    Rajwa, Pawel
    Briganti, Alberto
    Shariat, Shahrokh F.
    Matsubara, Nobuaki
    Kimura, Takahiro
    Hirakawa, Akihiro
    CANCER, 2025, 131 (07)
12345